BIO-Europe Spring^® 2014 Press Releases

March 14, 2013BIO-Europe Spring^® 2013 in Barcelona hosted over 2,000 executives from the life science sector The seventh annual BIO-Europe Spring^® international partnering conference concluded this week in Barcelona, Spain. The event, held March 11–13, 2013 at the CCIB Convention Centre Barcelona, welcomed more than 2,000 participants representing over 1,200 companies from 50 countries vying for an estimated 2,148 licensing opportunities. Close to 11,000 one-to-one meetings took pl...more ►

February 20, 2013VC Community is gearing up for BIO-Europe Spring^® 2013Investors will be a strong presence at partnering event
The seventh annual BIO-Europe Spring^® international partnering conference will be held at the CCIB Convention Centre Barcelona in Barcelona, Spain, March 11–13, 2013. High attendance by pharma and biotech investors and venture capital firms are expected at the event which will draw more than 2,000 executive-level attendees from over 1,300 companies. "Over recent years, th...more ►

January 24, 2013BIO-Europe Spring^® 2013 in Barcelona to feature C-level program speakersOpening Plenary and Defined Health track reflect the pulse of the industry
The seventh annual BIO-Europe Spring^® international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw over 2,000 attendees, 75% of whom represent C-level executives/ VPs and directors, from over 1,300 companies. "BIO-Europe Spring is our flagship companion event to BIO-Europe in ...more ►

December 11, 2012BIO-Europe Spring^® 2013 to bring international biopharma leaders to Barcelona for partnering The seventh annual BIO-Europe Spring^® international partnering conference will be held in Barcelona, Spain March 11–13, 2013 at the CCIB Convention Centre Barcelona. The event is expected to draw 2,000 attendees representing C-level executives and key decision makers from over 1,200 companies. "The Catalonia region has the infrastructure to support a dynamic life science ...more ►

3 May 2013 Roche is “building community” in China When Roche looks at China, it sees opportunities to access innovative technologies and leverage the expertise of very talented scientists, as well as opportunities to bring world-class drugs to a huge population with a growing demand for Western-style medicines. more ►

3 May 2013 China’s rapid growth nourishes biotech environment “Chinese investors haven’t lost a lot of money in biotech, so they’re in a good mood.” In the West, venture capital is drying up for life science firms so some small companies have come to Asia to raise financing where there is an available supply of money. more ►

18 March 2013 Elegant dysfunction in the push-pull of partnering Everything has changed in partnering on both sides of the table except the necessary tension for negotiating a good deal. Yet if the relations between VCs and pharma executives are strained, they still can't get enough of each other. more ►

18 March 2013 A view from the West: Trends in biotech venture exits The last year in biotech saw a breakout from prior performance on multiple fronts across stocks, drug approvals, venture returns, and pharma investing. more ►

18 March 2013 Stem cells: Do we need to wait 25 years for the Next Big Thing? With a Nobel Prize in 2012 and phenomenal potential for diagnostics and therapies, no one doubts that the next big thing will be stem cell derived products. In these (very) early days, this BIO-Europe Spring^® session presented current initiatives and challenges. more ►